Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

SWEDEHEART-1-year data show no benefit of newer generation drug-eluting stents over bare-metal stents in patients with severe kidney dysfunction following percutaneous coronary intervention.

Edfors R, James S, Szummer K, Evans M, Carrero JJ, Faxén J, Persson J, Spaak J, Varenhorst C, Jernberg T, Lagerqvist B.

Coron Artery Dis. 2019 Oct 23. doi: 10.1097/MCA.0000000000000814. [Epub ahead of print]

PMID:
31658144
2.

Food Web Uncertainties Influence Predictions of Climate Change Effects on Soil Carbon Sequestration in Heathlands.

Reyns W, Rineau F, Spaak JW, Franken O, Berg MP, Van Der Plas F, Bardgett RD, Beenaerts N, De Laender F.

Microb Ecol. 2019 Oct 25. doi: 10.1007/s00248-019-01444-1. [Epub ahead of print]

PMID:
31654107
3.

Treatments and Mortality Trends in Cases With and Without Dialysis Who Have an Acute Myocardial Infarction: An 18-Year Nationwide Experience.

Szummer K, Lindhagen L, Evans M, Spaak J, Koul S, Åkerblom A, Carrero JJ, Jernberg T.

Circ Cardiovasc Qual Outcomes. 2019 Sep;12(9):e005879. doi: 10.1161/CIRCOUTCOMES.119.005879. Epub 2019 Sep 12.

PMID:
31510770
4.

Changes in microparticle profiles by vitamin D receptor activation in chronic kidney disease - a randomized trial.

Lundwall K, Mörtberg J, Mobarrez F, Jacobson SH, Jörneskog G, Spaak J.

BMC Nephrol. 2019 Aug 1;20(1):290. doi: 10.1186/s12882-019-1445-4.

5.

Increased Inflammatory Activity in Patients 3 Months after Myocardial Infarction with Nonobstructive Coronary Arteries.

Hjort M, Eggers KM, Lindhagen L, Agewall S, Brolin EB, Collste O, Daniel M, Ekenbäck C, Frick M, Henareh L, Hofman-Bang C, Malmqvist K, Spaak J, Sörensson P, Y-Hassan S, Tornvall P, Lindahl B.

Clin Chem. 2019 Aug;65(8):1023-1030. doi: 10.1373/clinchem.2018.301085. Epub 2019 May 9.

PMID:
31072836
6.

Takotsubo twins.

Ekenbäck C, Tornvall P, Spaak J.

BMJ Case Rep. 2019 Apr 4;12(4). pii: e227885. doi: 10.1136/bcr-2018-227885.

PMID:
30948410
7.

Health care professionals' experiences and enactment of person-centered care at a multidisciplinary outpatient specialty clinic.

Evén G, Spaak J, von Arbin M, Franzén-Dahlin Å, Stenfors T.

J Multidiscip Healthc. 2019 Feb 14;12:137-148. doi: 10.2147/JMDH.S186388. eCollection 2019.

8.

Increased concentrations of platelet- and endothelial-derived microparticles in patients with myocardial infarction and reduced renal function- a descriptive study.

Mörtberg J, Lundwall K, Mobarrez F, Wallén H, Jacobson SH, Spaak J.

BMC Nephrol. 2019 Mar 1;20(1):71. doi: 10.1186/s12882-019-1261-x.

9.

Reply.

Völz S, Spaak J, Rundqvist B, Kahan T, Andersson B; all authors.

J Hypertens. 2019 Feb;37(2):449-451. doi: 10.1097/HJH.0000000000002012. No abstract available.

PMID:
30640875
10.

Personality Traits in Patients with Myocardial Infarction with Nonobstructive Coronary Arteries.

Nero D, Agewall S, Daniel M, Caidahl K, Collste O, Ekenbäck C, Frick M, Henareh L, Jernberg T, Malmqvist K, Schenck-Gustafsson K, Spaak J, Sörensson P, Sundin Ö, Y-Hassan S, Hofman-Bang C, Tornvall P.

Am J Med. 2019 Mar;132(3):374-381.e1. doi: 10.1016/j.amjmed.2018.11.010. Epub 2018 Nov 30.

PMID:
30503881
11.

Nya europeiska riktlinjer för behandling av hypertoni - Dags att återigen ta arteriell hypertoni på allvar.

Spaak J, Gottsäter A.

Lakartidningen. 2018 Oct 25;115. pii: FDXZ. Swedish. No abstract available.

12.

Treating endothelial dysfunction with vitamin D in chronic kidney disease: a meta-analysis.

Lundwall K, Jacobson SH, Jörneskog G, Spaak J.

BMC Nephrol. 2018 Sep 25;19(1):247. doi: 10.1186/s12882-018-1042-y.

13.

Prevalence of Anxiety and Depression Symptoms in Patients with Myocardial Infarction with Non-Obstructive Coronary Arteries.

Daniel M, Agewall S, Berglund F, Caidahl K, Collste O, Ekenbäck C, Frick M, Henareh L, Jernberg T, Malmqvist K, Schenck-Gustafsson K, Spaak J, Sundin Ö, Sörensson P, Y-Hassan S, Hofman-Bang C, Tornvall P.

Am J Med. 2018 Sep;131(9):1118-1124. doi: 10.1016/j.amjmed.2018.04.040. Epub 2018 Jun 1.

PMID:
29859805
14.

Outcomes in patients treated with ticagrelor versus clopidogrel after acute myocardial infarction stratified by renal function.

Edfors R, Sahlén A, Szummer K, Renlund H, Evans M, Carrero JJ, Spaak J, James SK, Lagerqvist B, Varenhorst C, Jernberg T.

Heart. 2018 Oct;104(19):1575-1582. doi: 10.1136/heartjnl-2017-312436. Epub 2018 Mar 24.

PMID:
29574413
15.

Renal sympathetic denervation in Sweden: a report from the Swedish registry for renal denervation.

Völz S, Spaak J, Elf J, Jägrén C, Lundin C, Stenborg A, Andersson J, Rundqvist B, Kahan T, Andersson B.

J Hypertens. 2018 Jan;36(1):151-158. doi: 10.1097/HJH.0000000000001517.

PMID:
29210862
16.

Kidney function is associated with short-term, mid-term and long-term clinical outcome after coronary angiography and intervention.

Panayiotou AG, Spaak J, Kalani M.

Acta Cardiol. 2018 Aug;73(4):362-369. doi: 10.1080/00015385.2017.1395546. Epub 2017 Oct 30.

PMID:
29082834
17.

Blood pressure response to renal denervation is correlated with baseline blood pressure variability: a patient-level meta-analysis.

Persu A, Gordin D, Jacobs L, Thijs L, Bots ML, Spiering W, Miroslawska A, Spaak J, Rosa J, de Jong MR, Berra E, Fadl Elmula FEM, Wuerzner G, Taylor AHM, Olszanecka A, Czarnecka D, Mark PB, Burnier M, Renkin J, Kjeldsen SE, Widimský J, Elvan A, Kahan T, Steigen TK, Blankestijn PJ, Tikkanen I, Staessen JA; European Network COordinating research on Renal Denervation (ENCOReD).

J Hypertens. 2018 Feb;36(2):221-229. doi: 10.1097/HJH.0000000000001582.

PMID:
29045339
18.

Shifts of community composition and population density substantially affect ecosystem function despite invariant richness.

Spaak JW, Baert JM, Baird DJ, Eisenhauer N, Maltby L, Pomati F, Radchuk V, Rohr JR, Van den Brink PJ, De Laender F.

Ecol Lett. 2017 Oct;20(10):1315-1324. doi: 10.1111/ele.12828. Erratum in: Ecol Lett. 2018 Mar;21(3):467.

19.

The value of a new cardiac magnetic resonance imaging protocol in Myocardial Infarction with Non-obstructive Coronary Arteries (MINOCA) - a case-control study using historical controls from a previous study with similar inclusion criteria.

Tornvall P, Brolin EB, Caidahl K, Cederlund K, Collste O, Daniel M, Ekenbäck C, Jensen J, Y-Hassan S, Henareh L, Hofman-Bang C, Lyngå P, Maret E, Sarkar N, Spaak J, Sundqvist M, Sörensson P, Ugander M, Agewall S.

BMC Cardiovasc Disord. 2017 Jul 24;17(1):199. doi: 10.1186/s12872-017-0611-5.

20.

Quantitation of 87 Proteins by nLC-MRM/MS in Human Plasma: Workflow for Large-Scale Analysis of Biobank Samples.

Rezeli M, Sjödin K, Lindberg H, Gidlöf O, Lindahl B, Jernberg T, Spaak J, Erlinge D, Marko-Varga G.

J Proteome Res. 2017 Sep 1;16(9):3242-3254. doi: 10.1021/acs.jproteome.7b00235. Epub 2017 Aug 8.

PMID:
28738677
21.

Outcomes associated to serum phosphate levels in patients with suspected acute coronary syndrome.

Xu H, Evans M, Gasparini A, Szummer K, Spaak J, Ärnlöv J, Lindholm B, Jernberg T, Carrero JJ.

Int J Cardiol. 2017 Oct 15;245:20-26. doi: 10.1016/j.ijcard.2017.07.050. Epub 2017 Jul 17.

PMID:
28734575
22.

Risk and predictors of readmission for heart failure following a myocardial infarction between 2004 and 2013: A Swedish nationwide observational study.

Desta L, Jernberg T, Spaak J, Hofman-Bang C, Persson H.

Int J Cardiol. 2017 Dec 1;248:221-226. doi: 10.1016/j.ijcard.2017.05.086. Epub 2017 May 24.

PMID:
28579167
23.

Novel combined management approaches to patients with diabetes, chronic kidney disease and cardiovascular disease.

Spaak J.

J R Coll Physicians Edinb. 2017 Mar;47(1):83-87. doi: 10.4997/JRCPE.2017.118. Review.

PMID:
28569290
24.

Vitamin D receptor activation reduces inflammatory cytokines and plasma MicroRNAs in moderate chronic kidney disease - a randomized trial.

Mansouri L, Lundwall K, Moshfegh A, Jacobson SH, Lundahl J, Spaak J.

BMC Nephrol. 2017 May 16;18(1):161. doi: 10.1186/s12882-017-0576-8.

25.

Potential of folate supplementation to reduce mortality in hypertensive patients.

Kahan T, Spaak J.

J Hypertens. 2017 Jun;35(6):1168-1169. doi: 10.1097/HJH.0000000000001352. No abstract available.

PMID:
28441258
26.

Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers Are Associated With Improved Outcome but Do Not Prevent New-Onset Atrial Fibrillation After Acute Myocardial Infarction.

Batra G, Lindhagen L, Andell P, Erlinge D, James S, Spaak J, Oldgren J.

J Am Heart Assoc. 2017 Mar 20;6(3). pii: e005165. doi: 10.1161/JAHA.116.005165.

27.

Intravenous beta-blocker therapy in ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention is not associated with benefit regarding short-term mortality: a Swedish nationwide observational study.

Mohammad MA, Andell P, Koul S, Desta L, Jernberg T, Omerovic E, Spaak J, Fröbert O, Jensen J, Engstrøm T, Hofman-Bang C, Persson H, Erlinge D.

EuroIntervention. 2017 Jun 2;13(2):e210-e218. doi: 10.4244/EIJ-D-16-01021.

PMID:
28242589
28.

Systematic underutilisation of secondary preventive drugs in patients with acute coronary syndrome and reduced renal function.

Khedri M, Szummer K, Carrero JJ, Jernberg T, Evans M, Jacobson SH, Spaak J.

Eur J Prev Cardiol. 2017 May;24(7):724-734. doi: 10.1177/2047487317693950. Epub 2017 Feb 14.

PMID:
28195517
29.

A Novel Microfluidic Assay for Rapid Phenotypic Antibiotic Susceptibility Testing of Bacteria Detected in Clinical Blood Cultures.

Malmberg C, Yuen P, Spaak J, Cars O, Tängdén T, Lagerbäck P.

PLoS One. 2016 Dec 14;11(12):e0167356. doi: 10.1371/journal.pone.0167356. eCollection 2016.

30.

Long-term versus short-term dual antiplatelet therapy was similarly associated with a lower risk of death, stroke, or infarction in patients with acute coronary syndrome regardless of underlying kidney disease.

Carrero JJ, Varenhorst C, Jensevik K, Szummer K, Lagerqvist B, Evans M, Spaak J, Held C, James S, Jernberg T.

Kidney Int. 2017 Jan;91(1):216-226. doi: 10.1016/j.kint.2016.09.014. Epub 2016 Nov 16.

PMID:
27865441
31.

Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Myocardial Infarction Patients With Renal Dysfunction.

Evans M, Carrero JJ, Szummer K, Åkerblom A, Edfors R, Spaak J, Jacobson SH, Andell P, Lindhagen L, Jernberg T.

J Am Coll Cardiol. 2016 Apr 12;67(14):1687-97. doi: 10.1016/j.jacc.2016.01.050.

32.

Renal function is associated with long-term outcomes independent of degree of atherosclerosis: 6-year data from the Swedish Coronary Angiography and Angioplasty Registry.

Edfors R, Szummer K, Evans M, Carrero JJ, Spaak J, James S, Lagerqvist B, Jernberg T.

Eur Heart J Qual Care Clin Outcomes. 2016 Apr 1;2(2):91-98. doi: 10.1093/ehjqcco/qcv029.

PMID:
29474624
33.

Increased fibrin formation and impaired fibrinolytic capacity in severe chronic kidney disease.

Mörtberg J, Blombäck M, Wallén Å, He S, Jacobson SH, Spaak J.

Blood Coagul Fibrinolysis. 2016 Jun;27(4):401-7. doi: 10.1097/MBC.0000000000000462.

PMID:
26650459
34.
35.

Paricalcitol, Microvascular and Endothelial Function in Non-Diabetic Chronic Kidney Disease: A Randomized Trial.

Lundwall K, Jörneskog G, Jacobson SH, Spaak J.

Am J Nephrol. 2015;42(4):265-73. doi: 10.1159/000441364. Epub 2015 Oct 24.

PMID:
26496210
36.

Risk Factors and Markers for Acute Myocardial Infarction With Angiographically Normal Coronary Arteries.

Daniel M, Ekenbäck C, Agewall S, Brolin EB, Caidahl K, Cederlund K, Collste O, Eurenius L, Frick M, Younis-Hassan S, Henareh L, Jernberg T, Malmqvist K, Spaak J, Sörensson P, Hofman-Bang C, Tornvall P.

Am J Cardiol. 2015 Sep 15;116(6):838-44. doi: 10.1016/j.amjcard.2015.06.011. Epub 2015 Jun 25.

PMID:
26251000
38.

Association between the use of fondaparinux vs low-molecular-weight heparin and clinical outcomes in patients with non-ST-segment elevation myocardial infarction.

Szummer K, Oldgren J, Lindhagen L, Carrero JJ, Evans M, Spaak J, Edfors R, Jacobson SH, Andell P, Wallentin L, Jernberg T.

JAMA. 2015 Feb 17;313(7):707-16. doi: 10.1001/jama.2015.517.

PMID:
25688782
39.

Renal nerve stimulation to predict responders to renal denervation.

Kahan T, Spaak J.

J Hum Hypertens. 2015 May;29(5):281-2. doi: 10.1038/jhh.2014.109. Epub 2014 Nov 20. No abstract available.

PMID:
25411055
40.

Time courses of central hemodynamics during rapid changes in posture.

Sundblad P, Spaak J, Kaijser L.

J Appl Physiol (1985). 2014 May 1;116(9):1182-8. doi: 10.1152/japplphysiol.00690.2013. Epub 2014 Mar 13.

41.

Warfarin, kidney dysfunction, and outcomes following acute myocardial infarction in patients with atrial fibrillation.

Carrero JJ, Evans M, Szummer K, Spaak J, Lindhagen L, Edfors R, Stenvinkel P, Jacobson SH, Jernberg T.

JAMA. 2014 Mar 5;311(9):919-28. doi: 10.1001/jama.2014.1334.

PMID:
24595776
42.

Inverse relationship of subjective daytime sleepiness to sympathetic activity in patients with heart failure and obstructive sleep apnea.

Taranto Montemurro L, Floras JS, Millar PJ, Kasai T, Gabriel JM, Spaak J, Coelho FMS, Bradley TD.

Chest. 2012 Nov;142(5):1222-1228. doi: 10.1378/chest.11-2963.

PMID:
23303285
43.

Regression of vascular calcification in chronic kidney disease - feasible or fantasy? a review of the clinical evidence.

Leonard O, Spaak J, Goldsmith D.

Br J Clin Pharmacol. 2013 Oct;76(4):560-72. doi: 10.1111/bcp.12014. Review.

44.

Integrating virtual patients into courses: follow-up seminars and perceived benefit.

Edelbring S, Broström O, Henriksson P, Vassiliou D, Spaak J, Dahlgren LO, Fors U, Zary N.

Med Educ. 2012 Apr;46(4):417-25. doi: 10.1111/j.1365-2923.2012.04219.x.

PMID:
22429178
45.

[Vitamin D deficiency in kidney failure. Risk factor for cardiovascular disease].

Ohman K, Larsson T, Spaak J.

Lakartidningen. 2010 Nov 17-23;107(46):2884-7. Review. Swedish. No abstract available.

PMID:
21197784
46.

Dose-related effects of red wine and alcohol on heart rate variability.

Spaak J, Tomlinson G, McGowan CL, Soleas GJ, Morris BL, Picton P, Notarius CF, Floras JS.

Am J Physiol Heart Circ Physiol. 2010 Jun;298(6):H2226-31. doi: 10.1152/ajpheart.00700.2009. Epub 2010 Apr 23.

47.

Effects of deep and superficial experimentally induced acute pain on skin sympathetic nerve activity in human subjects.

Burton AR, Birznieks I, Spaak J, Henderson LA, Macefield VG.

Exp Brain Res. 2009 May;195(2):317-24. doi: 10.1007/s00221-009-1790-9. Epub 2009 Apr 14.

PMID:
19365628
48.

Dose-related effects of red wine and alcohol on hemodynamics, sympathetic nerve activity, and arterial diameter.

Spaak J, Merlocco AC, Soleas GJ, Tomlinson G, Morris BL, Picton P, Notarius CF, Chan CT, Floras JS.

Am J Physiol Heart Circ Physiol. 2008 Feb;294(2):H605-12. Epub 2007 Nov 30.

49.

Comparison of muscle sympathetic activity in ischemic and nonischemic heart failure.

Notarius CF, Spaak J, Morris BL, Floras JS.

J Card Fail. 2007 Aug;13(6):470-5.

PMID:
17675061
50.

Muscle sympathetic nerve activity during wakefulness in heart failure patients with and without sleep apnea.

Spaak J, Egri ZJ, Kubo T, Yu E, Ando S, Kaneko Y, Usui K, Bradley TD, Floras JS.

Hypertension. 2005 Dec;46(6):1327-32. Epub 2005 Nov 14.

PMID:
16286569

Supplemental Content

Support Center